(Q42956374)

11 November 2017

title

Update on emerging therapies for multiple sclerosis (English)

1 reference

11 November 2017

Eppie M Yiu

1

1 reference

11 November 2017

Brenda Banwell

series ordinal

2

1 reference

11 November 2017

publication date

1 August 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

11 November 2017

published in

1 reference

11 November 2017

volume

10

1 reference

11 November 2017

issue

8

1 reference

11 November 2017

page(s)

1259-1262

1 reference

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

11 November 2017

cites work

1 reference

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis

21 January 2018

1 reference

Stem cell transplantation in multiple sclerosis: current status and future prospects

21 January 2018

1 reference

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.10.98

1 reference

11 November 2017

1 reference